SPOTLIGHT: Stem cell therapy for bones nearing human trials

by admin |


An Edinburgh University team of researchers has been using a bioactive scaffold to help spur stem cells to grow into bone or cartilage. The researchers say the approach can be tested in humans in two years for severe trauma. Report

Suggested Articles

Indian Flag
Biotech

Zydus advances COVID-19 vaccine after clearing safety test

Zydus Cadila has completed a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 .

by Nick Paul Taylor
Unlocked Money
Biotech

Novartis, high profile backers fund next-gen Treg startup

OrbiMed, Novartis Venture Fund and RA Capital Management have joined forces to fund and help launch GentiBio.

by Ben Adams
Novavax vaccine
Biotech

Novavax’s COVID-19 vaccine looks promising in early data

A month after scoring $1.6 billion from the U.S. government, Novavax is posting the first human data from its COVID-19 vaccine.

by Amirah Al Idrus